Trial Profile
A Study to Compare the Effect of Rosuvastatin and Simvastatin on High Density Lipoprotein (HDL) Subfractions in Patients with Metabolic Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Simvastatin (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- 16 Dec 2015 New trial record